share_log

海正药业(600267.SH):目前从合成生物学的技术手段在做一些项目推进

Haizheng Pharmaceutical (600267.SH): Currently working on some projects using synthetic biological techniques

Gelonghui Finance ·  Dec 26, 2023 06:01

Gelonghui, December 26丨Haizheng Pharmaceutical (600267.SH) said on an interactive platform that the “Productivity Promotion Award” was approved by the Ministry of Science and Technology and the National Science and Technology Award Office, and Haizheng Pharmaceutical's “Key Technology and Application for Industrialization of Anthracyclics Antineoplastic Drugs” project won the first prize of the “2022 Productivity Promotion (Innovation and Development) Award”. The company has always attached importance to the application of microbial technology and enzyme catalysis technology in pharmaceutical process development. It has built genetic modification platforms for various strains such as actinomycetes, yeast, and Escherichia coli. In recent years, with the increasing maturity of gene editing and targeted evolution technology, research and development has accelerated the application of new technologies in technological upgrading of key varieties. Currently, it is working on some projects using synthetic biology techniques.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment